|
|
.
See Category: Diseases of the skin and subcutaneous tissue
See Header: Primary focal hyperhidrosis
ICD-10 (CM) Code and Descriptor
|
L74.512 |
Primary focal hyperhidrosis, palms
|
L74512 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 31.78%
|
21.71%
|
18.60%
|
8.53%
|
4.65%
|
6.20%
|
0.78%
|
2.33%
|
1.55%
|
1.55%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for L74.512*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
J0585
|
INJECTION,ONABOTULINUMTOXINA |
12
|
2,355
|
|
64999
|
UNLISTED PX NERVOUS SYSTEM |
11
|
11
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
11
|
11
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
7
|
7
|
|
84443
|
ASSAY THYROID STIM HORMONE |
7
|
7
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
6
|
106
|
|
J3010
|
FENTANYL CITRATE INJECTION |
5
|
8
|
|
99213
|
OFFICE O/P EST LOW 20 MIN |
5
|
5
|
|
81025
|
URINE PREGNANCY TEST |
3
|
3
|
|
J2405
|
ONDANSETRON HCL INJECTION |
3
|
12
|
|
80053
|
COMPREHEN METABOLIC PANEL |
3
|
3
|
|
J7120
|
RINGERS LACTATE INFUSION |
2
|
2
|
|
86140
|
C-REACTIVE PROTEIN |
2
|
2
|
|
17110
|
DESTRUCT B9 LESION 1-14 |
2
|
2
|
|
84439
|
ASSAY OF FREE THYROXINE |
2
|
2
|
|
82570
|
ASSAY OF URINE CREATININE |
2
|
2
|
|
83835
|
ASSAY OF METANEPHRINES |
2
|
2
|
|
11900
|
INJECT SKIN LESIONS |
2
|
2
|
|
83036
|
HEMOGLOBIN GLYCOSYLATED A1C |
2
|
2
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
2
|
2
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
L74.512 related to the following DRG Codes:
606-607
|
